NUWE Quote, Financials, Valuation and Earnings

Hologic, Inc. has a net margin of 21.11% compared to Nuwellis, Inc.'s net margin of 17.85%. Nuwellis, Inc.'s return on equity of -1004.06% beat Hologic, Inc.'s return on equity of 11.59%.

Nuwellis, Inc. has a consensus price target of $13.00, signalling upside risk potential of 23000.02%. On the other hand Hologic, Inc. has an analysts' consensus of $76.42 which suggests that it could grow by 2.07%. Given that Nuwellis, Inc. has higher upside potential than Hologic, Inc., analysts believe Nuwellis, Inc. is more attractive than Hologic, Inc..

Nuwellis, Inc. has a beta of -0.186, which suggesting that the stock is 118.573% less volatile than S&P 500. In comparison Hologic, Inc. has a beta of 0.695, suggesting its less volatile than the S&P 500 by 30.493%.

Nuwellis, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hologic, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nuwellis, Inc. pays -- of its earnings as a dividend. Hologic, Inc. pays out -- of its earnings as a dividend.

Nuwellis, Inc. quarterly revenues are $2.2M, which are smaller than Hologic, Inc. quarterly revenues of $1B. Nuwellis, Inc.'s net income of $468K is lower than Hologic, Inc.'s net income of $187.3M. Notably, Nuwellis, Inc.'s price-to-earnings ratio is -- while Hologic, Inc.'s PE ratio is 30.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nuwellis, Inc. is 0.54x versus 4.15x for Hologic, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

PAVmed, Inc. has a net margin of 21.11% compared to Nuwellis, Inc.'s net margin of -120220%. Nuwellis, Inc.'s return on equity of -1004.06% beat PAVmed, Inc.'s return on equity of 8.75%.

Nuwellis, Inc. has a consensus price target of $13.00, signalling upside risk potential of 23000.02%. On the other hand PAVmed, Inc. has an analysts' consensus of $9.50 which suggests that it could grow by 3809.47%. Given that Nuwellis, Inc. has higher upside potential than PAVmed, Inc., analysts believe Nuwellis, Inc. is more attractive than PAVmed, Inc..

Nuwellis, Inc. has a beta of -0.186, which suggesting that the stock is 118.573% less volatile than S&P 500. In comparison PAVmed, Inc. has a beta of 1.106, suggesting its more volatile than the S&P 500 by 10.577%.

Nuwellis, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PAVmed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nuwellis, Inc. pays -- of its earnings as a dividend. PAVmed, Inc. pays out -- of its earnings as a dividend.

Nuwellis, Inc. quarterly revenues are $2.2M, which are larger than PAVmed, Inc. quarterly revenues of $5K. Nuwellis, Inc.'s net income of $468K is higher than PAVmed, Inc.'s net income of -$6M. Notably, Nuwellis, Inc.'s price-to-earnings ratio is -- while PAVmed, Inc.'s PE ratio is 0.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nuwellis, Inc. is 0.54x versus 3,405.62x for PAVmed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Quanterix Corp. has a net margin of 21.11% compared to Nuwellis, Inc.'s net margin of -83.31%. Nuwellis, Inc.'s return on equity of -1004.06% beat Quanterix Corp.'s return on equity of -30.04%.

Nuwellis, Inc. has a consensus price target of $13.00, signalling upside risk potential of 23000.02%. On the other hand Quanterix Corp. has an analysts' consensus of $7.33 which suggests that it could fall by -9.02%. Given that Nuwellis, Inc. has higher upside potential than Quanterix Corp., analysts believe Nuwellis, Inc. is more attractive than Quanterix Corp..

Nuwellis, Inc. has a beta of -0.186, which suggesting that the stock is 118.573% less volatile than S&P 500. In comparison Quanterix Corp. has a beta of 1.006, suggesting its more volatile than the S&P 500 by 0.60500000000001%.

Nuwellis, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quanterix Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nuwellis, Inc. pays -- of its earnings as a dividend. Quanterix Corp. pays out -- of its earnings as a dividend.

Nuwellis, Inc. quarterly revenues are $2.2M, which are smaller than Quanterix Corp. quarterly revenues of $40.2M. Nuwellis, Inc.'s net income of $468K is higher than Quanterix Corp.'s net income of -$33.5M. Notably, Nuwellis, Inc.'s price-to-earnings ratio is -- while Quanterix Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nuwellis, Inc. is 0.54x versus 2.51x for Quanterix Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Varex Imaging Corp. has a net margin of 21.11% compared to Nuwellis, Inc.'s net margin of 5.33%. Nuwellis, Inc.'s return on equity of -1004.06% beat Varex Imaging Corp.'s return on equity of -13.35%.

Nuwellis, Inc. has a consensus price target of $13.00, signalling upside risk potential of 23000.02%. On the other hand Varex Imaging Corp. has an analysts' consensus of $17.20 which suggests that it could grow by 28.07%. Given that Nuwellis, Inc. has higher upside potential than Varex Imaging Corp., analysts believe Nuwellis, Inc. is more attractive than Varex Imaging Corp..

Nuwellis, Inc. has a beta of -0.186, which suggesting that the stock is 118.573% less volatile than S&P 500. In comparison Varex Imaging Corp. has a beta of 0.861, suggesting its less volatile than the S&P 500 by 13.881%.

Nuwellis, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Varex Imaging Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nuwellis, Inc. pays -- of its earnings as a dividend. Varex Imaging Corp. pays out -- of its earnings as a dividend.

Nuwellis, Inc. quarterly revenues are $2.2M, which are smaller than Varex Imaging Corp. quarterly revenues of $228.9M. Nuwellis, Inc.'s net income of $468K is lower than Varex Imaging Corp.'s net income of $12.2M. Notably, Nuwellis, Inc.'s price-to-earnings ratio is -- while Varex Imaging Corp.'s PE ratio is 17.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nuwellis, Inc. is 0.54x versus 0.70x for Varex Imaging Corp.. Usually stocks with elevated PS ratios are considered overvalued.